Top Bioinformatics Startups in 2024

Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the development of breakthrough products.

H1 was built by scientists for scientists. We empower stakeholders at healthcare and life science companies to make smarter scientific decisions by providing access to critical data through an intuitive interface. Working with some of the largest and most influential global life science organizations, H1 provides insight into thought leaders, scholarly content, academics, and healthcare professionals with much more on the way.

Founded to improve lives with high-value care, hc1 has emerged as the bioinformatics leader in precision testing and prescribing. The cloud-based hc1 Platform organizes live data, including lab results, genomics, and medications, to deliver solutions that ensure the right patient gets the right test and the right prescription. Today, the hc1 Platform powers two flagship solutions hc1 Lab CRM and hc1 Test Utilization™, as well as breakthrough precision prescribing innovations hc1 Opioid Advisor™ and hc1 PGx Advisor™. To learn more about hc1’s proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit hc1.com and follow us on Twitter, Facebook, and LinkedIn.

Maybe you’ve supported a friend or family member who’s dealing with cancer. Maybe you’ve battled it yourself. At Syapse, our mission is to enable healthcare providers to deliver the best care to every cancer patient through precision medicine and it's our personal connections to this mission that unites us Together, we're building a revolutionary suite of products that integrate complex oncology data and share insights across the cancer care ecosystem including cancer care centers and life science companies developing the next generation of cancer diagnostics and medicines. Join us in our exciting mission to scale precision medicine to reach every cancer patient on the planet. All while making a positive impact in the lives of people battling cancer, their families and the organizations committed to their care.

Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market. The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

Causaly’s mission is to accelerate the pace of human discovery in biomedicine and to power the research organizations of the world’s largest life sciences companies to accelerate their drug discovery and development programs. We do this by developing easy-to-use AI tools to find and qualify scientific facts and collaborate effectively across multidisciplinary teams. Our technology mimics human reading, and digests tens of millions of scientific documents, clinical trial, labels, news and other data sources at super human scale to generate a high precision Science Knowledge Graph allowing scientists, investigators, researchers and others to answer questions they can’t answer anywhere else.

Autonomize Health is a human-centered AI company that is democratizing access to data to power human health outcomes. Our software automates deep insights from multi-structured clinical data and biomedical literature to accelerate clinical research, provide value based care and power precision medicine. Our early life sciences customers reduced their time to recruit patients to clinical trials by 50% and expect to save over 60% of their costs by de-risking the clinical trials outcomes.

Genomics is transforming medicine but data analysis and interpretation are the biggest bottlenecks. Basepair’s mission is for scientists, physicians, and ultimately people to extract actionable insights from genomic data to help with healthcare research, drug discovery, and personal health decisions. Basepair is an enterprise B2B SaaS for analytics and visualization of genomics data. Our customers include biopharma, molecular diagnostics, services, and some of the world’s top medical hospitals, e.g., Harvard Medical School, Stanford Univ, etc. We are funded by VCs, angel investors and have a front-row seat for the latest breakthroughs in life sciences.

CANCER FUND is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at cancerfund.com.